| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-10 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |